Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis

Hemasphere. 2022 Feb 15;6(3):e688. doi: 10.1097/HS9.0000000000000688. eCollection 2022 Mar.

Authors

Nora Liebers^{1

2}, Stefan O Schönland¹, Claudius Speer³, Dominic Edelmann⁴, Paul Schnitzler⁵, Hans-Georg Kräusslich⁵, Carsten Mueller-Tidow^{1

2}, Ute Hegenbart¹, Sascha Dietrich^{1

2

6}

Affiliations

¹ Department of Medicine V, Heidelberg University Hospital, Germany.
² National Center for Tumor Diseases Heidelberg, Germany.
³ Department of Nephrology, Heidelberg University Hospital, Germany.
⁴ German Cancer Research Center, Division of Biostatistics, Heidelberg, Germany.
⁵ Department of Infectious Diseases, Virology, Heidelberg University Hospital, Germany.
⁶ European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.

No abstract available